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impairment in non-stroke individuals with WMH on MRI com-
pared to individuals without WMH. We then performed a 
sensitivity analysis by excluding studies with certain charac-
teristics and repeating the meta-analysis calculation.  Re-
sults: After screening 11,001 potentially suitable titles, we 
included 37 papers reporting 32 studies of 20,379 subjects: 
15 of stroke patients and 17 of SVD features in non-stroke 
patients. To diagnose lacunar stroke, 13/15 of the studies 
used risk factor-based classification (none used diffusion-
weighted MRI). 394/1,119 (35%) of patients with lacunar 
stroke had renal impairment compared with 1,443/4,217 
(34%) of patients with non-lacunar stroke, OR 0.88, (95% CI 
0.6–1.30). In individuals without stroke the presence of SVD 
was associated with an increased risk of renal impairment 
(whether proteinuria or reduced eGFR) OR 2.33 (95% CI 1.80–
3.01), when compared to those without SVD. After adjust-
ment for age and hypertension, 15/21 studies still reported a 
significant association between renal impairment and SVD. 
 Conclusion: We found no specific association between renal 
impairment and lacunar stroke, but we did find that in indi-
viduals who had not had a stroke, having more SVD features 
on imaging was associated with a worse renal function, 
which remained significant after controlling for hyperten-
sion. However, this finding does not exclude a powerful co-
associate effect of age or vascular risk factor exposure. Future 
research should subtype lacunar stroke sensitively and con-
trol for major risk factors.   © 2014 S. Karger AG, Basel 
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 Abstract 
 Background: The small vessel disease (SVD) that appears in 
the brain may be part of a multisystem disorder affecting oth-
er vascular beds such as the kidney and retina. Because renal 
failure is associated with both stroke and white matter hyper-
intensities we hypothesised that small vessel (lacunar) stroke 
would be more strongly associated with renal failure than 
cortical stroke. Therefore, we performed a systematic review 
and meta-analysis to establish first if lacunar stroke was as-
sociated with the renal function, and second, if cerebral small 
vessel disease seen on the MRI of patients without stroke was 
more common in patients with renal failure.  Methods: We 
searched Medline and EMBASE for studies in adults with ce-
rebral SVD (lacunar stroke or white matter hyper intensities 
(WMH) on Magnetic Resonance Imaging (MRI)), in which re-
nal function was assessed (estimated glomerular filtration 
rate (eGFR) or proteinuria). We extracted data on SVD diag-
nosis, renal function, demographics and comorbidities. We 
performed two meta-analyses: first, we calculated the odds 
of renal impairment in lacunar (small vessel) ischaemic stroke 
compared to other ischaemic stroke subtypes (non-small 
vessel disease); and second, we calculated the odds of renal 
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 Introduction 
 Impaired kidney function is associated with an in-
creased risk of stroke  [1] , and reduced estimated glomer-
ular filtration rate (eGFR) is associated with an increased 
risk of cerebral small vessel disease (SVD) such as white 
matter hyperintensities (WMH)  [2] , and lacunes. It has 
been proposed that SVD is a manifestation of an underly-
ing multi-system endothelial disorder affecting the small 
vessels of the kidney, brain, heart, and retina  [3] , possibly 
mediated through inflammation  [4, 5] .
 All studies of renal function and SVD are faced with 
the challenge of disentangling whether these disorders 
are a common consequence from shared risk factors or 
represent a causative relationship. One way of doing this 
is to compare patients with different stroke subtypes, 
that is, to compare patients with lacunar (small vessel) 
stroke to patients with other stroke subtypes, or to com-
pare the prevalence of renal disease in individuals with 
imaging-determined SVD features. We hypothesised 
that: patients presenting with a symptomatic recent isch-
aemic lacunar stroke may have a greater risk of renal 
impairment than patients with the other ischaemic 
stroke subtypes that are associated with embolism or 
large vessel disease. Additionally, individuals  without 
symptomatic stroke  may be at increased risk of SVD on 
imaging if they have renal impairment, after risk factor 
adjustment. 
 We performed a systematic review of the literature to 
establish first the risk of renal impairment in patients with 
lacunar stroke compared to patients in other ischaemic 
stroke subtypes, and second, the risk of renal impairment 
in non-stroke participants with SVD features on imaging 
(e.g. WMH, lacunes) compared to those without SVD. 
 Methods 
 We followed the ‘Preferred Reporting Items for Systematic Re-
views and Meta-Analyses’ (PRISMA) guidelines  [6] . We searched 
MEDLINE (1966–present) and EMBASE (1981–present) using 
OVID (version OvidSP_UI03.08.01.105), using the search terms 
in the Supplementary Information – last search was conducted on 
April 2013. SM and FABC independently reviewed the titles to 
identify the relevant papers and extracted the data. We resolved the 
disagreements through mutual discussion and consultation with 
JMW. We hand-searched the past editions of the journal ‘Stroke’, 
and the abstracts of presentations at European Stroke Conferences 
from 2006–2013 (published in Cerebrovascular Diseases), and the 
reference lists of relevant review papers. We deemed a paper to be 
potentially relevant if it included a reference to the measurement 
of renal function or mentioned SVD in adult humans in the title, 
and then went on to read the whole paper. 
 We included studies that measured the renal function in living 
humans with either symptomatic lacunar stroke or imaging fea-
tures of SVD. We included studies that described WMH, lacunes, 
or ‘silent cerebral infarcts’, as these terms are commonly used to 
refer to SVD on imaging  [7, 8] , but excluded atrophy as this was 
inconsistently reported. We excluded studies that were performed 
on animals or post mortem, that measured renal disease but did 
not investigate the renal function (e.g. studies of renal biopsy find-
ings), and studies that only included participants with renal im-
pairment.
 We extracted data on study population; location (community 
or hospital); inclusion and exclusion criteria; diagnosis of stroke 
subtype; the details of any imaging and image analysis methods; 
the definition used of SVD; how renal function was measured and 
defined; blinding; the differences in risk factors between the par-
ticipants with and without stroke/SVD; the numbers of partici-
pants with and without stroke/imaging features of SVD who had 
renal impairment; and any adjusted or unadjusted summary sta-
tistics such as Odds Ratios (OR). We contacted the authors if it was 
apparent that the data had been acquired but was not reported in 
the paper. 
 We considered renal impairment to be either a reduced eGFR 
(<60 ml/min, Stage 3 Chronic Kidney Disease) or albuminuria – 
either micro (30–300 ml/l) or macro (>300 ml/l). For the purpose 
of the meta-analysis, we used the definitions of renal impairment, 
lacunar stroke, and SVD from the individual studies within our 
overall definition. 
 We carried out two meta-analyses. First, we compared the risk 
of renal impairment in patients with lacunar stroke to patients in 
other ischaemic stroke sub-groups. Second, we compared the risk 
of renal impairment in non-stroke participants with SVD on imag-
ing to those without SVD. The meta-analysis included all the stud-
ies in that had dichotomised participants into those with and with-
out renal impairment. If a study gave the mean and standard de-
viation (SD) of the eGFR, we assumed a normal distribution and 
calculated the number of patients with an eGFR below 60. We used 
a random effects model to account for differences in underlying 
study methodology. We performed analyses using Stats Direct 
(StatsDirect statistical software version 2.7.9 http://www. stats 
 direct.com. England: StatsDirect Ltd., 2008) and RevMan (Version 
5, Cochrane Collaboration). 
 Each meta-analysis followed the same procedure. We calcu-
lated the summary OR of all studies using the Mantel-Haenszel 
random effects model and assessed heterogeneity using the I 2 sta-
tistic. We used a funnel plot to examine for publication bias. To 
assess the causes of heterogeneity and the risk of bias in individual 
studies we performed a sensitivity analysis by excluding certain 
studies with various characteristics and repeating the meta-analy-
sis. Lastly, we examined the summary statistics of the individual 
studies that had carried out a multivariable analysis accounting for 
age and hypertension. No protocol was published externally. 
 Results 
 We identified 11,001 potentially suitable titles ( fig. 1 ). 
Of these, we excluded 1,0676 titles because they did not 
refer to either renal function, or SVD in adults, and read 
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the abstract or full paper of the remaining 325 references. 
We excluded 246 studies because they did not measure 
both renal function and SVD, two because they were pub-
lished only in abstract, 20 because they only included pa-
tients with established kidney disease, 14 because they did 
not report the renal function of patients by stroke subtype 
and a further two because they only included one particu-
lar stroke sub-type. Full details of excluded studies are 
available on request. 
 We included 38 papers describing 32 studies of 20,379 
participants: 15 studies  [9–23] (45 of studies, 37% of pa-
tients) of stroke patients, and 17 studies  [24–42] of 
healthy volunteers or non-stroke patients who had SVD 
defined on imaging alone (55 of studies, 63% of partici-
pants). 
 Critical Appraisal of 15 Studies of Stroke Patients  
 Study characteristics are summarised in  tables 1 and  2 . 
Thirteen studies  [9, 10, 13–19, 21–23, 43] (87 of studies 
of stroke patients, 88% of stroke patients) recorded stroke 
subtype (lacunar or non-lacunar), while three recorded 
renal function in stroke patients with and without WMH 
on Magnetic Resonance Imaging (MRI)  [9, 11, 12] .
 Most studies were from developed countries and var-
ied with respect to inpatient and outpatient recruitment. 
One study  [20] (n = 958) included only young patients 
with a stroke but the rest included all ages (overall the 
mean age was 67). All studies measured the renal function 
as soon as possible after stroke, with the exception of one 
study of 96 patients which assessed renal function 6–8 
weeks post-stroke  [14] .
 Characteristics of the 13 Studies that Subtyped Stroke 
 Of the 13 studies that subtyped the stroke, only one 
 [16] used the Oxfordshire Community Stroke Project 
(OCSP)  [44] classification (8 of studies, 7% of sub-typed 
stroke patients); all other studies used the risk-factor 
based Trial of Org 10,172 in Acute Stroke Treatment 
(TOAST) classification  [45] . No studies used diffusion 
weighted MRI (DWI-MRI) in the acute phase. Four stud-
ies measured proteinuria  [13, 14, 19, 22] (31 of studies, 
9% of sub-typed stroke patients), and nine  [9, 15–18, 20–
15 studies reported
renal function in
patients with
lacunar and 
non-lacunar
ischaemic stroke
Included
14 studies did
not report
renal function
by stroke
sub-type
Excluded
31 studies measured renal
function in patients with
lacunar and non-lacunar
ischaemic stroke
246 studies did not 
measure renal function or
small vessel disease
2 studies published
in abstract only
46 studies measured renal
function in non-stroke
patients with and without
cerebral small vessel disease
10,686 did not
measure to
renal function or
small vessel
disease
11,001 titles
325 abstracts
3 studies measured
SVD and renal
function but did
not report renal
function by SVD
Excluded
20 studies of
patients with
known CKD
only
Excluded
23 studies
compared renal
function in 
non-stroke 
patients with and
without SVD
Included
2 studies
excluded
one sub-type
of stroke
Excluded
 Fig. 1. Flow chart of search results.  
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Table 1.  Characteristics of studies included in the systematic review
Study and population Lacunar 
stroke
definition
Imaging Definition 
of renal 
impairment
Lacunar
ischaemic 
stroke
impaired/total
Non-lacunar
ischaemic 
stroke
impaired/total
Studies which compared renal function between lacunar and non-lacunar stroke
Beamer 
[14], 1999
USA
Setting: 2 hospitals
Included: 96 patients up to 7 days post-stroke
Excluded: UTI and dialysis 
TOAST not clear proteinuria
>20 mg/l
17/54 11/42
Das [10], 
2012
Bangladesh
Setting: neurology department 
Included: 60 patients up to 4 weeks post-stroke
Excluded: known CKD
TOAST CT/MRI proteinuria 
20–200 ml/l
13/42 6/18
MacWalter 
[16], 2002
UK
Setting: teaching hospital 
Included: 488 patients 48 h post stroke
Excluded: dialysis
OCSP CT eGFR <66 121/134 302/354
Rodríguez-
Yáñez [13],
2006 
Spain
Setting: teaching hospital 
Included: 200 patients within 24 h
Excluded: TPA/trial drug, brainstem stroke or known renal 
disease
TOAST CT proteinuria
<30 mg/l
4/33 45/167
Tsagalis 
[19], 2009 
Greece
Setting: teaching hospital stroke data bank
Included: 2,155 patients <48 h post stroke with 2× 
 creatinine measurements
Excluded: previous stroke
TOAST CT >50% increase 
in creatinine 
from baseline
72/378 403/1454
Naganuma 
[21], 2011 
Japan
Setting: registry of thrombolysis patients in 10 stroke units
Included: 578 patients who were thrombolysed for  
ischaemic stroke
Excluded: patients disabled prior to stroke
TOAST CT/MRI eGFR <60 5/28 181/550
Mostofsky 
[18], 2009
USA
Setting: emergency department
Included: 1,175 consecutive patients
Excluded: IN-hospital stroke
TOAST CT/MRI eGFR <60 105/339 286/836
Ueda [9],
2011
Japan
Setting: stroke unit
Included: 202 consecutive ischaemic stroke  patients
Excluded: acute kidney injury
TOAST MRI eGFR <60 12/38 44/164
Putaala 
[20], 2011
Finland
Setting: Helsinki young stroke registry 
Included: 958 first stroke patients age 15–19
Excluded: incomplete data or creatinine  measured 30 days 
post-stroke
TOAST not clear eGFR <60 17/130 26/828
Hoshino 
[17], 2012
Japan
Setting: Neurology Department 
Included:475 stroke patients 
Excluded: severe renal dysfunction, pre stroke disability
TOAST CT eGFR <60 29/92 88/235 
Kudo [22], 
2012 
Japan
Setting: single hospital
Included: 525 stroke patients
Excluded: missing data
TOAST CT/MRI eGFR <60 and/or 
proteinuria
24/60 168/264
Tsukamoto 
[23], 2012 
Japan
Setting: neurology department
Included: 639 consecutive stroke patients
Excluded: dialysis patients
TOAST CT/MRI eGFR <60 32/104 207/535
Chinda 
[15], 2012
Japan
Setting: single hospital 
Included: 451 consecutive stroke patients
Excluded: presented later than 7 days after stroke
TOAST CT/MRI eGFR <60 15/65 79/224
Studies which compared renal function in stroke patients with WMH to those without WMH
Oksala 
[11], 2010
Finland
Setting: single hospital
Included: 378 consecutive ischaemic stroke  patients aged 
55–85
Excluded: patients who were not Finnish or not living in 
Helsinki 
NA 1.0T 
MRI
eGFR <60 96/203 56/175
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Study Patients Imaging Definition SVD Measure of 
renal function
Subjects with 
SVD impaired/
total
Subjects 
 without SVD 
impaired/
total
Studies of patients with MR imaging features of SVD, but no symptomatic stroke
Uzu [38],
2010
Japan 
Setting: diabetic outpatient clinic 
Included: 608 type 2 diabetic 
Excluded: IHD, cancer, steroid use, heavy  proteinuria 
300 ml/l+, renal impairment
1.5T 
MRI
1+ SBI 
definition 
not given
micro 
 albuminuria 
(30–299 ml/l) 
95/1772 188/431
Ikram 
[30],
2008
Netherlands
Setting: Rotterdam study: population based study of 7,983 
participants over 50
Included: subgroup of 484 participants aged 60–90 
stratified by sex and age
Excluded: patients with known dementia, or who could not 
have MRI
1.5T 
MRI
automated 
 measurement 
of WMH  
volume
eGFR for each SD decrease in eGFR 
there was a significant  increase 
in OR of WMH 0.16 (0.04–
0.29)
de Bresser 
[27],
2010
Netherlands
Setting: patients aged 56–80 with diabetes recruited though 
their General Practitioners
Included: 122 patients with Type 2 diabetes
Excluded: patients with psychiatric and  neurological 
 disorders, heavy alcohol use and  dementia
1.5T 
MRI
automated 
 measurement 
of WMH 
 volume
albuminuria 
>0.03 g/l
baseline albuminuria was 
 associated with a non- 
significant increase in WMH 
at 2 years
Seliger [34],
2005 
USA 40 
Setting: Cardiovascular Health Study 
5,888 individuals over 65 selected randomly from medicare 
lists
Included: 2,784 participants selected for MRI
Excluded: previous stroke and TIA
not clear 1+ infarct-like 
lesion ≥3 mm in 
a patient  without 
a  history of 
stroke
eGFR <60 237/789 484/1,9952
Giele [29],
2004
Netherlands
Setting: second manifestations of ARTertial disease 
(SMART) study
Included: 308 patients with first presentation of 
 atherosclerotic disease
Excluded: previous stroke or TIA
1.5T 
MRI
1+ CSF filled 
lesion 
≥3 mm 
mild renal 
 impairment: 
eGFR 80–50 
Severe renal 
impairment 
eGFR <50 
age adjusted OR for presence of 
silent infarcts in: 
mild renal impairment 1.6 
(0.7–3.5)
Severe renal impairment 7.3 
(2.1–25.2)
Wada [39], 
2007; [40], 
2008; [41], 
2010
Japan
Setting: population study of all 61 and 72 year olds from 
two towns
Included: 608 participants
Excluded: history of stroke, current UTI
0.3 & 
0.5T 
MRI 
Fazekas score 
of either 2 or 
3 (not specified 
whether deep or 
periventricular)
presence of 
micro 
albuminuria: 
cut off not clear
95/177 188/431
eGFR <60 or 
urinary ACR <30
70/143 157/508
Cystatin C OR of moderate or severe 
WMH, per SD increase in 
 cystine C 1.48 (1.22–1.78) 
 (unadjusted)
Weiner [42],
2009
USA 
Setting: clients of a home care service for low income people 
over 60
Included: 319 participants
Excluded: participants who were unable to consent, 
 non-English speakers, had a visual or hearing disability, on 
dialysis or unable to provide a urine specimen
1.5T 
MRI 
a score of 2/10 
or more on an 
unvalidated 
qualitative 
WMH rating 
scale
micro-
albuminuria 
(17 mg/g+ in 
men and 
25 mg/g+ in 
women)
88/214 29/105
Table 1. (continued)
Study and population Lacunar 
stroke
definition
Imaging Definition 
of renal 
impairment
Lacunar
ischaemic 
stroke
impaired/total
Non-lacunar
ischaemic 
stroke
impaired/total
Rost 
[12], 2010
USA
Setting: Emergency Department
Included: 523 consecutive ischaemic stroke  patients
Excluded: patients without a lesion on MRI
NA 1.5T 
MRI 
eGFR as a 
 continuous 
relationship
low eGFR correlated with 
WMH volume, r = –0.003, 
p = 0.002
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Table 1. (continued)
Study Patients Imaging Definition SVD Measure of 
renal function
Subjects with 
SVD impaired/
total
Subjects 
 without SVD 
impaired/
total
Otani 
[32],
2010
Japan
Setting: population study of one town
Included: 1,008 participants aged over 55
Excluded: previous stroke or TIA
0.5T 
MRI
at least 1 
 hyperintensity 
on T2 between 
3 and 15 mm
eGFR <60 100/286 186/722
Bouchi 
[25],
2010
Japan
Setting: patients with type 2 diabetes who had an MRI for 
any reason at a single hospital
Included: 786 participants
Excluded: patients with type 1 DM, pregnancy, infection, 
cancer, or eGFR under 15
1.5T 
MRI
T2 
hyperintensity 
≥3 mm 
eGFR <60 182/415 75/371
Chou [26],
2011
Taiwan
Setting: healthy volunteers from Taipai City
Included: 1,312 participants
Excluded: previous stroke, current fever, eGFR <30
1.5T 
MRI
T2 
 hyperintensity
≥3 mm 
eGFR 30–60 10/62 37/1,250
Anan [24],
2008
Japan
Setting: outpatient endocrinology clinic 
Included: 90 patients with type 2 diabetes
Excluded: patients with IHD, macro-albuminuria, high 
 creatinine, or insulin use
1.5T 
MRI
the presence of 
WMH with 
Fazekas score 
≥2 – unclear if 
deep or 
periventricular
urinary 
albumin in the 
range of 
30–299 mg/24 h
27/34 20/56
Eguchi [28],
2004
Japan
Setting: asymptomatic patients having an annual health 
check
Included: 170 patients aged 42–89 with 3 or more vascular 
risk factors
Excluded: renal or liver failure, secondary or malignant 
 hypertension
0.5T 
MRI
at least 1 
 hyperintensity 
on T2 between 
3 and 15 mm
correlation 
 between serum 
creatinine and 
no of WMH 
serum creatinine correlated 
with number of WMH, r = 0.2, 
p < 0.006
Khatri [31],
2007
USA
Setting: randomly selected residents of Manhattan
Included: 615 participants over 40 who had a telephone 
and could consent
Excluded: those with a history of stroke or eGFR <15
1.5T 
MRI
automated 
 measurement 
of WMH 
volume
correlation 
 between 
 creatinine 
 clearance and 
WMH volume
creatinine clearance of 15–60 
ml/linked to log WMH volume 
(0.322; 95% CI, 0.095–0.550)
Takahashi 
[35],
2012
Japan
Setting: asymptomatic patients presenting for a ‘brain 
check’.
Included: 2,043 healthy volunteers. 
Excluded: participants with a history of stroke, neurological, 
or heart diseases
1.5T 
MRI 
score of ≥2 on 
Fazekas score – 
deep and 
 periventricular 
lesions analysed 
separately
eGFR <60 deep WMH 
89/465
deep WMH
156/1,571
periventricular 
WMH:
51/221
periventricular 
WMH:
194/1,822
Takami [36],
2012
Japan 
Setting: outpatient hypertension clinic
Included: 185 participants
Excluded: patients with AF
1.5T 
MRI
deep WMH: 
cases if Fazekas 
score ≥2. 
Periventricular 
WMH cases if 
Fazekas score ≥1
eGFR <60 deep WMH
31/75
deep WMH
16/1102 
periventricular 
WMH
36/102
periventricular 
WMH 
10/832
Turner [37],
2011
USA
Setting: members of sibling pairs where one was 
hypertensive
Included: 1,585 participants
Excluded: secondary hwypertension, known CKD and 
previous stroke
1.5T 
MRI
automated 
 measurement 
of WMH 
volume on 
FLAIR
correlation 
 between serum 
creatinine and 
WMH volume
correlation between serum 
creatinine and WMH volume. 
Age adjusted correlation 
 coefficient = 0.54 
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23] measured eGFR. No studies reported whether there 
were any differences in vascular risk factors between pa-
tients with lacunar and non-lacunar stroke. 
 Characteristics of 17 Studies of Non-Stroke Patients  
 Seventeen studies  [24–42, 46, 47] of 13,164 partici-
pants (mean age 65) measured renal function and MRI 
features of SVD in participants without a symptomatic 
stroke ( tables 1 and  2 ). Eight studies  [26, 30–35, 39] were 
of healthy volunteers; four were of diabetic patients (10% 
of subjects); two  [28, 29] were of patients with any of a 
variety of vascular risk factors, one was of hypertensive 
patients alone  [36] , and another included both hyperten-
sive patients and their siblings (12% of subjects)  [34, 37] .
 Ten studies  [24–26, 28, 29, 32, 34, 36, 38, 39] reported 
the blood pressure of participants with and without SVD 
(either as the percent of subjects previously diagnosed 
with hypertension or as the mean systolic blood pressure 
on examination), and two studies  [24, 36] reported little 
difference between the participants with and without 
SVD (a difference of less than 2% in the proportion of 
participants or a difference of less than 5 mm Hg in sys-
tolic blood pressure between groups). 
 Ten studies  [26, 28, 29, 31, 32, 34, 37–39] excluded par-
ticipants with previous stroke, nine  [24–26, 28, 31, 33, 38, 
39, 42] excluded those with the most severe renal impair-
ment, and all measured the MRI features of SVD. 
 Five studies  [24, 28, 35, 36, 38, 40] used a method such 
as the Fazekas score  [48] to grade WMH, six  [25, 26, 29, 
32, 34, 38] counted the number of silent brain infarcts, 
and five  [27, 30, 31, 37, 42] used an automated measure 
to quantify the volume of WMH. Nine studies  [24, 26–29, 
33, 34, 36, 41, 42] (46% of participants) were read by an 
observer blinded to the clinical details. Eight studies  [26, 
27, 30, 31, 34–37] (70% of non-stroke participants) mea-
sured eGFR, six  [24, 25, 33, 38, 39, 42] measured protein-
uria, three  [28, 32, 40] measured both, and one study  [29] 
measured serum creatinine. Thirteen studies  [24–32, 34–
36, 39, 42] carried out a multivariate analysis accounting 
for (at least) age and hypertension. Twelve papers treated 
SVD as a binary variable (i.e., present or absent) and per-
formed binary logistic regression, while seven treated it 
as a continuous variable and used linear regression.
 Meta-Analysis of the Risk of Renal Impairment in 
Lacunar Stroke Versus Other Stroke Subtypes  
 First, we performed a meta-analysis of the studies re-
porting the numbers of lacunar and non-lacunar stroke 
patients with renal impairment (defined as proteinuria or 
an eGFR below 60 ml/min): 12 studies of 5,338 patients 
 [9, 10, 13–18, 20–23] . We excluded a study of patients 
who suffered deterioration in renal function after stroke 
 [19] and two studies of stroke patients that measured 
WMH volume, not stroke subtype  [11, 12]. 
 Overall there was no specific association between renal 
function and stroke subtype – lacunar versus non-lacunar: 
394/1,119 (35%) of patients with lacunar stroke had renal 
impairment, compared with 1,443/4,217 (34%) of patients 
with non-lacunar stroke ( fig. 2 ) OR 0.88, 95% confidence 
interval (CI) 0.61–1.28. There was a high degree of hetero-
geneity (inconsistency) with an I2 of 76%. When compar-
ing patients with lacunar and non-lacunar stroke there 
was no statistically significant difference in the odds of 
proteinuria, OR 0.79 (95% CI 0.38–1.67), or eGFR <60, 
Study Patients Imaging Definition SVD Measure of 
renal function
Subjects with 
SVD impaired/
total
Subjects 
 without SVD 
impaired/
total
Ravera 
[33], 2002
Italy
Setting: patients from one centre who were enrolled in a 
large study on complications of microalbuminuria in 
 untreated patients with mild-moderate hypertension
Included: 22 patients with microalbuminuria, 22 controls 
without
Excluded: patients with cancer, liver disease, IHD, diabetes, 
obesity, and Dementia
1.5T
MRI
a count of 
 number of 
 lacuanes: 3–15 
mm lesion dark 
on T1, light on 
T2
no of lacunes in 11 patients with 
 microalbuminuria against the number of lacunas 
in 11 patients without microalbuminuria 82 of 
patients with microalbuminuria had incident 
lacunes vs. 27% of patients without
 1 All studies excluded patients unable to have MRI; 2 Calculated from mean and SD assuming a normal distribution. UTI = Urinary tract infection; 
TOAST = trial of org 10,172 in acute stroke treatment; CKD = chronic kidney disease; CT = computerised topography; MRI = magnetic resonance imaging; 
OCSP = oxfordshire community stroke project; eGFR = estimated glomular filtration rate;  TPA = tissue plasminogen antigen; WMH = white matter hyper-
intensities; SD = standard deviation; IHD = ischaemic heart disease; TIA =  transient ischaemic attack; CSF = cerebrospinal fluid; OR = odds ratio; ACR = 
albumin creatinine ratio.
Table 1. (continued)
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OR 1.02 (95% CI: 0.66–1.56). No studies of stroke patients 
performed a multivariable analysis accounting for risk 
factors. Funnel plots (online suppl. fig. A, B; see www.
karger.com/doi/10.1159/000 369777) did not indicate 
publication bias. 
 Sub-group analysis ( fig.  3 ) suggested an association 
between lacunar stroke and impaired renal function in 
younger patients: a study that only included participants 
aged 15–49  [20] found a fourfold risk of renal impairment 
when compared to other subtypes, OR 4.64 (95% CI: 
Table 2.  Summary of characteristics of studies
Characteristic Number of studies % of studies % of subjects
Stroke patients 14 45 37
Non stroke 17 55 63
Studies of stroke patients % of studies of stroke patients % of stroke patients
Recorded stroke sub-type 13 87 88
Inpatients and outpatients 1 7 1.2
Inpatients only 12 80 96
USA 3 20 22
Europe 5 33 48
Asia 7 47 29
Studies of subtyped stroke patients % of studies that subtyped stroke % of patients with 
subtyped stroke 
OCSP 1 8 7
TOAST 12 92 93
CT Imaging 4 31 40
MRI 2 15 12
CT and MRI 4 31 17
Measured proteinuria 4 31 9
Measured eGFR 9 69 69
Patients that developed acute kidney injury 1 8 26
Studies of imaging features of SVD patients % of studies of imaging 
features of SVD
% of subjects in the
studies of imaging 
features of SVD
Healthy volunteers 8 47 57
Diabetic patients 4 24 10
Any vascular risk factor 2 12 4
Hypertensive patients 1 6 0.2
Hypertensive patients and their siblings 1 6 11
Excluded previous stroke 10 59 84
Excluded severe renal impairment 9 53 35
1.5T 14 82 86
0.5T 3 18 14
Fazekas or similar 5 29 24
Count of silent brain infarcts 6 35 52
Automated measure of the volume of WMH 5 29 24
Images analysed by a blinded observer 9 53 46
Measured eGFR 8 47 70
Measured proteinuria 5 29 13
Measured both 3 18 14
Measured serum creatinine 1 6 2
Multivariate analysis 13 76 81
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0.002 0.1 1 10
Cortical
Heterogeneity: Tau2 = 0.29; Chi2 = 34.55, d.f. = 7 (p < 0.0001); I2 = 80%
Test for overall effect: Z = 0.07 (p = 0.94)
Heterogeneity: Tau2 = 0.29; Chi2 = 46.41, d.f. = 11 (p < 0.00001); I2 = 76%
Test for overall effect: Z = 0.66 (p = 0.51)
Test for subgroup differences: Chi2 = 7.23, d.f. = 2 (p = 0.03); I2 = 72.3%
Heterogeneity: Not applicable
Test for overall effect: Z = 3.29 (p = 0.0010)
Total (95% CI)
Total events
Heterogeneity: Tau2 = 0.15; Chi2 = 3.01, d.f. = 2 (p = 0.22); I2 = 34%
Test for overall effect: Z = 0.61 (p = 0.54)
1.1.1 Proteinuria
Beamer 1999
Rodriguez-Yanez 2006
Das 2012
Subtotal (95% CI)
Total events
17
4
13
34
54
33
42
129
34
11
45
6
62
42
167
18
227
7.1%
5.8%
5.4%
18.3%
1.29 [0.53, 3.17]
0.37 [0.12, 1.12]
0.90 [0.28, 2.91]
0.79 [0.38, 1.67]
1.1.2 eGFR <60
Chinda 2012
Hoshino 2012
MacWalter 2002
Mostofsky 2009
Naganuma 2011
Putaala 2011
Ueda 2011
Tsukamoto 2012
Subtotal (95% CI)
Total events
15
29
121
105
5
17
12
32
336
65
92
134
339
28
130
38
104
930
79
88
302
286
181
26
44
207
1,213
224
235
354
836
550
828
164
535
3,726
8.9%
9.8%
8.8%
11.3%
6.5%
8.8%
7.9%
10.2%
72.4%
0.55 [0.29, 1.04]
0.77 [0.46, 1.28]
1.60 [0.84, 3.05]
0.86 [0.66, 1.13]
0.44 [0.17, 1.18]
4.64 [2.44, 8.82]
1.26 [0.58, 2.71]
0.70 [0.45, 1.11]
1.02 [0.66, 1.56]
1.1.3 Protienuria or eGFR <60
Kudo 2012
Subtotal (95% CI)
Total events
24
24
394
60
60
1,119
168
168
1,443
264
264
4,217
9.3%
9.3%
100.0%
0.38 [0.21, 0.68]
0.38 [0.21, 0.68]
0.88 [0.61, 1.28]
Lacunar
Events Total Events Total Weight
Non-lacunar Odds Ratio
M-H, Random, 95% Cl
Odds Ratio
M-H, Random, 95% ClStudy or subgroup
Lacunar
500
Young stroke
All ages: mean age 60–70 years
All ages: mean age 70+
OCSP
TOAST
Inpatients only
Inpatients and outpatients
USA
Europe
Asia
4.64 (2.44, 8.82)
0.74 (0.58, 1.08)
0.71 (0.47, 1.00)
1.60 (0.84, 3.05)
0.83 (0.57, 1.23)
0.86 (0.58, 1.27)
1.29 (0.53, 3.17)
0.89 (0.69, 1.10)
1.50 (0.42, 5.41)
0.65 (0.49, 0.85)
0.2 0.5 1 2 5 10
Renal impairment more
common
in non-lacunar stroke
Renal impairment more
common
in lacunar stroke
 Fig. 2. A forest plot demonstrating the re-
sults of the meta-analysis of studies of renal 
function in patients with lacunar and corti-
cal stroke. 
Fig. 3. The Odds Ratio of renal impairment 
in patients with lacunar stroke compared 
to other stroke sub-type for different sub-
groups of studies.  
 2 
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2.44–8.82); whereas in studies of patients with a mean age 
of 70 or greater there was no significant difference be-
tween subtypes. In Asian studies (Japan  [9, 15, 17, 21–23] , 
and Bangladesh  [10] ) patients with lacunar stroke had a 
reduced risk of renal impairment OR 0.65 (95% CI 0.49–
0.85). Neither the method of stroke sub-typing (OCSP or 
TOAST), nor a study that recruited only inpatients, af-
fected the lack of association between lacunar stroke sub-
type and renal impairment. 
 Meta-Analysis of the Risk of Renal Impairment in 
Non-Stroke Participants 
 We included 12 studies  [24–26, 32, 34–36, 38–40, 42, 46] 
of 11,269 participants in this analysis. We excluded studies 
that only measured Cystatin C  [41] or serum creatinine 
 [29] ; those that used microalbuminuria as the dependent 
variable  [33] ; or those that did not dichotomise renal im-
pairment or SVD  [30, 31, 37, 47] . For the two studies  [35, 
36] that did not report a total WMH score but instead re-
ported the findings for deep and periventricular WMH 
separately, we included the data for periventricular lesions 
in the meta-analysis, as these are more prevalent. Two stud-
ies reported the results of eGFR and proteinuria in separate 
papers  [32, 39, 40, 49] ; therefore, we ensured that each par-
ticipant only contributed once to each calculation.
 Unadjusted Odds of Renal Impairment in Participants 
with and without Imaging Features of Small Vessel 
Disease 
 The OR of renal impairment (either eGFR or protein-
uria) in participants with SVD compared to those without 
was 2.33 (95% CI 1.80–3.01), with an I 2 of 78.2% ( fig. 4 ). 
0.01 0.1 1 10
No SVD
Heterogeneity: Tau2 = 0.19; Chi2 = 24.58, d.f. = 4 (p < 0.0001); I2 = 84%
Test for overall effect: Z = 4.09 (p < 0.0001)
Heterogeneity: Tau2 = 0.00; Chi2 = 0.43, d.f. = 1 (p = 0.51); I2 = 0%
Test for overall effect: Z = 5.00 (p < 0.00001)
Heterogeneity: Tau2 = 0.13; Chi2 = 46.86, d.f. = 10 (p < 0.00001); I2 = 79%
Test for overall effect: Z = 6.46 (p <0.00001)
Test for subgroup differences: Chi2 = 7.69, d.f. = 2 (p = 0.02); I2 = 74.0%
Total (95% CI)
Total events
Heterogeneity: Tau2 = 0.15; Chi2 = 9.49, d.f. = 3 (p = 0.02); I2 = 68%
Test for overall effect: Z = 4.23 (p < 0.0001)
1.1.1 Fazekas Score 2+
Anan 2008
Takahashi 2012
Takami 2012
Wada 2008
Subtotal (95% CI)
Total events
27
51
36
70
184
34
221
102
153
510
20
194
10
157
381
56
1,822
83
472
2,433
4.4%
10.5%
5.9%
10.2%
31.0%
1.1.2 At least 1 SBI
Bouchi 2009
Chou 2011
Longstreth 2002
Otani 2010
Uzu 2010
Subtotal (95% CI)
Total events
182
10
40
100
95
427
75
37
140
114
188
554
415
62
254
286
177
1,194
371
1,250
1,179
722
431
3,953
10.8%
6.1%
10.1%
10.8%
10.4%
48.3%
1.1.3 Other score similar to Fazekas
Seliger 2005
Weiner 2009
Subtotal (95% CI)
Total events
237
88
325
936
721
214
935
2,639
1,995
105
2,100
8,486
12.1%
8.6%
20.7%
100.0%
484
29
513
1,448
SVD
Events Total Events Total Weight
Non-SVD Odds Ratio
M-H, Random, 95% Cl
Odds Ratio
M-H, Random, 95% ClStudy or subgroup
SVD
100
6.94 [2.57, 18.78]
2.52 [1.78, 3.56]
3.98 [1.83, 8.65]
1.69 [1.17, 2.45]
2.81 [1.74, 4.54]
3.08 [2.24, 4.24]
6.30 [2.97, 13.37]
1.39 [0.95, 2.03]
2.87 [2.09, 3.93]
1.50 [1.05, 2.13]
2.44 [1.59, 3.74]
1.53 [1.27, 1.84]
1.83 [1.10, 3.04]
1.56 [1.31, 1.86]
2.33 [1.80, 3.01]
 Fig. 4. Meta-analysis of the risk of renal impairment in non-stroke patients with SVD compared to those without SVD.  
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Studies that recorded ‘silent brain infarcts’ had a higher 
degree of heterogeneity (I 2 84%), which may represent the 
range of different lesions described as ‘silent brain in-
farcts’. Further meta-analysis of the unadjusted data re-
vealed that participants with SVD were twice as likely to 
have proteinuria compared with participants without 
SVD: OR 2.00 (95% CI 1.44–2.78) with a moderate degree 
of heterogeneity (I 2 54.1%); and almost three times as 
likely to have an eGFR <60, OR 2.82 (95% CI 1.94–4.10), 
but with a high degree of heterogeneity: I 2 84.4%.
 We investigated whether the relationship between 
SVD and renal function varied in studies of particular 
groups of participants ( fig. 5 ). For studies of younger pa-
tients (average age 50–60) there was a stronger relation-
ship between impaired renal function and SVD (OR 3.19, 
95% CI 1.69–6.01) in comparison with studies of patients 
over 70 (OR 1.53, 95% CI 1.53–1.79). Other study factors 
had little consistent effect on the relationship between re-
nal function and SVD. A funnel plot (online suppl. fig. B) 
revealed little evidence of publication bias. 
Population study
Study of diabetic patients
Study of hypertensive patients
Study of house bound elderly patients
Prior stroke included
Prior stroke excluded
Prior renal failure included
Prior renal failure excluded
Average age 50–60
Average age 60–70
Average age 70+
0–1 years difference in age between SVD and no SVD
1–4 years difference in age
5+ years difference in age
30–50% of subjects hypertensive
50–70% of subjects hypertensive
70–100% of subjects hypertensive
20–25% difference in hypertension between SVD and no SVD
Under 2% difference
2.16 (1.56, 2.99)
2.81 (1.40, 5.62)
3.98 (1.83, 8.65)
1.83 (1.10, 3.04)
2.63 (1.62, 4.27)
2.18 (1.59, 2.99)
2.14 (1.51, 3.02)
2.59 (1.70, 3.95)
3.19 (1.69, 6.01)
2.64 (1.92, 3.64)
1.53 (1.31, 1.79)
2.90 (0.60, 14.03)
1.93 (1.30, 2.87)
2.51 (1.40, 4.50)
3.94 (1.83, 8.49)
2.49 (1.38, 4.50)
2.42 (1.06, 5.54)
2.89 (1.60, 5.22)
3.19 (1.21, 8.38)
0.5 1 2 5 10 100
Renal function worse
in patients without
SVD
Renal function worse
in patients with
SVD
 Fig. 5. The Odds Ratio of renal impairment in non-stroke patients with small vessel disease compared to those without for different 
subgroups of studies.  
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 Risk Factor Adjusted Odds of Renal Impairment in 
Participants with and without Imaging Features of 
Small Vessel Disease 
 Nineteen studies  [24–32, 34–37, 39, 40, 42, 46, 47, 49] 
calculated odds ratios adjusted for age, hypertension and 
a variety of other risk factors; but we could not carry out 
a meta-analysis of the adjusted ORs as all studies adjusted 
for slightly different parameters. 
 After adjusting for (at least) age and hypertension, 
nine studies  [24–27, 31, 35, 42, 46, 47] reported a signifi-
cant association between renal function and SVD, but 
with a smaller OR than the unadjusted statistic. However, 
three studies  [28, 34, 37] reported no significant link be-
tween renal function and SVD after adjustment for age 
and hypertension; one  [49] found a significant link be-
tween proteinuria and SVD, but not between eGFR and 
SVD; one  [30] found a significant link between renal im-
pairment for participants with periventricular, but not 
deep WMH, whereas another  [36] found that there was a 
significant link between renal impairment and deep (but 
not periventricular) WMH. 
 Discussion 
 Participants with cerebral SVD features on imaging 
were found to be at increased risk of renal impairment 
compared to participants without SVD, but patients with 
a symptomatic lacunar stroke were at no more risk of re-
nal impairment than patients with a non-lacunar stroke.
 An association between lacunar sub-type and renal 
impairment could have been missed by the studies of 
stroke patients because the sub-typing (largely based on 
clinical and CT diagnosis) was not sufficiently precise to 
distinguish lacunar from non-lacunar stroke  [50] . No 
studies used a gold-standard means of stroke sub-typing, 
namely risk-factor free clinical sub-typing aided by 
DWI-MRI in the acute phase. As some studies  [51] have 
suggested that lacunar stroke affects patients at a young-
er age than non-lacunar stroke, the lack of adjustment 
for age in the analysis of patients with symptomatic 
stroke may have masked an association between lacunar 
stroke subtype and impaired renal function. In a study 
of younger patients  [20] there was a stronger association 
between impaired renal function and lacunar stroke 
than with other stroke subtypes, which is interesting as 
an association between renal function and lacunar stroke 
may not be present across all age groups as it could be 
diluted by older patients having more heterogeneous 
risk factors. 
 We did not investigate whether the different non-lacu-
nar sub-types were associated with renal impairment as 
we were investigating the association between small ves-
sel disease and renal impairment. 
 There was a high level of heterogeneity throughout the 
literature with different methods of measuring SVD, 
stroke sub-type, proteinuria, and eGFR. No studies re-
ported differences in risk factors between patients with 
and without lacunar stroke, which limited our investiga-
tion of covariates such as hypertension. Almost all studies 
measured renal impairment in the acute phase, leading to 
potential confounding by dehydration, which is common 
after stroke  [52] .
 This work has been hampered by the lack of a stan-
dardised definition of SVD, with various studies using 
definitions such as silent brain infarcts, and ‘lacunes’ to 
represent similar imaging findings. This problem was 
compounded by various definitions of proteinuria/albu-
minuria. Future studies should use the recently published 
standardised imaging definitions of SVD  [7] .
 The strengths of this review include a comprehensive 
literature search incorporating studies from America, 
 Europe and Asia with no language exclusions. In addition 
to the relationship between reduced eGFR and silent le-
sions investigated by Vogels et al.  [2] we have included 
patients with proteinuria, symptomatic stroke, and a me-
ta-analysis. Weaknesses comprise the inclusion of only 
dichotomised studies in the meta-analysis: some more re-
cent studies investigated the continuous relationship be-
tween WMH volume and renal impairment. We were not 
able to fully investigate the effects of powerful confound-
ing factors (e.g. age and hypertension), because it was not 
possible to carry out a meta-analysis of the adjusted ORs 
from multivariate analysis as they had all corrected for 
different confounders. 
 The apparently strong link between ‘silent’ SVD and 
renal impairment in studies of stroke-free patients was 
not seen in studies of symptomatic stroke. This calls into 
question the hypothesis that cerebral and renal SVD are 
directly associated as part of the same multi-system dis-
ease rather than representing end organ damage from 
shared risk factors particularly of hypertension. How-
ever, it is difficult to draw firm conclusions due to a high 
degree of heterogeneity and imprecise stroke sub-typ-
ing.
 Studies of non-stroke participants should use age-
matched controls and carry out multivariate analysis of 
confounding factors. As over 10,000 participants have al-
ready undergone MRI and the measurement of renal 
function, it should be possible to achieve this by re-anal-
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ysis of the existing data using a well-resourced individual 
patient data meta-analysis. Future studies of stroke pa-
tients should perform careful sub-typing using risk fac-
tor-free clinical classification (i.e. OCSP  [44] aided by 
early DWI-MRI), measure proteinuria and eGFR outside 
the acute phase, and compare with age-matched non-la-
cunar stroke controls accounting for variations in risk 
factors. 
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